GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Sets September 4 Record Date for Rs. 4 Dividend

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 29 Jul 2026, 06:36 PM IST  ·  BSE ID: 4b0674b9-29aa-4092-bb4e-c092bd76d82f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has set a date to identify shareholders eligible for its dividend payment.
🤖 AI Summary
  • Jagsonpal Pharmaceuticals sets September 4, 2026, as the record date for its Rs. 4 dividend.
  • The Rs. 4 (200%) per equity share dividend is for the financial year ended March 31, 2026.
  • Shareholder approval for the dividend is required at the 47th AGM on September 18, 2026.
  • The AGM will be held via Video Conferencing, with dividend payment within 30 days of approval.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Dividend per equity share
Rs. 4 (200% )
Face value per equity share
Rs. 2
Record Date
September 04, 2026
Annual General Meeting Date
September 18, 2026
🏢 How This Affects the Company
💰
Financial Impact
The proposed dividend payment will reduce the company's retained earnings and cash balance upon approval and disbursement.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders. Ensure holdings are in demat account by September 4, 2026, to be eligible for the dividend if approved.
👤
Who Is Affected
All shareholders of Jagsonpal Pharmaceuticals Limited as of September 4, 2026, will be entitled to receive the dividend if approved.
🔍
Management Signal
Management is proceeding with the proposed dividend distribution, signaling a commitment to shareholder returns.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM outcome on September 18, 2026, for dividend approval.
Dividend payment within 30 days of AGM approval.
Company's next quarterly results announcement.
LOW RISK Routine dividend announcement and record date setting with no new significant risks flagged.
💡 Investor Takeaway
Jagsonpal Pharmaceuticals confirmed September 4, 2026, as the record date for a Rs. 4 per equity share dividend for FY26, pending shareholder approval at the September 18, 2026 AGM.
⚖️ Strengths & Concerns

✅ Positives

  • Proposed Rs. 4 (200%) dividend per equity share for FY26, subject to shareholder approval at AGM.
  • Fixed record date of September 4, 2026, provides clarity for shareholders regarding dividend entitlement.
📅 Company Track Record
Previously, on April 27, 2026, Jagsonpal Pharmaceuticals board recommended a dividend for FY26, with quantum and terms to be announced later.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is Jagsonpal Pharmaceuticals' dividend per share for FY26?
Jagsonpal Pharmaceuticals recommended a dividend of Rs. 4 (200%) per equity share for the financial year ended March 31, 2026.
When is the record date for Jagsonpal Pharmaceuticals' FY26 dividend?
The record date for determining entitlement to the dividend is Friday, September 04, 2026.
When will Jagsonpal Pharmaceuticals' AGM be held for dividend approval?
The 47th Annual General Meeting of Jagsonpal Pharmaceuticals, where the dividend is subject to shareholder approval, will be held on Friday, September 18, 2026.
How will the FY26 dividend be paid by Jagsonpal Pharmaceuticals?
The dividend, if approved at the AGM, shall be paid within 30 days from its declaration, subject to applicable taxes.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.